Gearing up for the prospect of the UK departing from the EU without a deal, biopharma companies are preparing with different precautions costing upward of $100 million per company. Novartis on Friday ...
The draft Brexit deal between Britain and the European Union was made possible by a breakthrough over the Irish border, but it could still prove the issue that unravels the agreement. Both sides ...
Britain’s decision to leave the European Union in 2016 was sold to voters as a magic bullet that would revitalize the country’s economy. Its impact is still reverberating. By Mark Landler Reporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results